Latest Articles

Publication Date
An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target.

Endometriosis is a chronic, heterogeneous disease with limited non-hormonal treatment options. Drug repurposing provides an accelerated route to identify safe, tolerable, and potentially effective therapies for endometriosis. Receptor tyrosine kinase-like …

Published: Dec. 3, 2025, midnight
Emerging roles and therapeutic potential of tRNA-Derived small RNAs in reproductive system diseases: a review.

tRNA-derived small RNAs (tsRNAs) are a class of non-coding RNAs(ncRNAs) generated from precursor or mature tRNAs under stress conditions, such as starvation, hypoxia, or oxidative stress. They are broadly classified …

Published: Dec. 3, 2025, midnight
Sask. woman with endometriosis says diagnosis after 11 years was a ‘relief’ - MSN

Sask. woman with endometriosis says diagnosis after 11 years was a ‘relief’ MSN

Published: Dec. 2, 2025, 11:26 p.m.
Sask. woman with endometriosis says diagnosis after 11 years was a ‘relief’ - Yahoo News Canada

Sask. woman with endometriosis says diagnosis after 11 years was a ‘relief’ Yahoo News Canada

Published: Dec. 2, 2025, 11:23 p.m.
Lexington mother–daughter team pushes for faster endometriosis diagnosis and better care in Mass. - Yahoo

Lexington mother–daughter team pushes for faster endometriosis diagnosis and better care in Mass. Yahoo

Published: Dec. 2, 2025, 9:59 p.m.
Global shift towards imaging for endometriosis diagnosis highlighted in new IJGO study - FIGO.org

Global shift towards imaging for endometriosis diagnosis highlighted in new IJGO study FIGO.org

Published: Dec. 2, 2025, 5:25 p.m.
How invisible symptoms and provider bias delay endometriosis diagnosis - Contemporary OB/GYN

How invisible symptoms and provider bias delay endometriosis diagnosis Contemporary OB/GYN

Published: Dec. 2, 2025, 2:02 p.m.
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence - Morningstar

Ziwig Endotest®: Scientific Validation Published in NEJM Evidence Morningstar

Published: Dec. 2, 2025, 2 p.m.
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence - PR Newswire

Ziwig Endotest®: Scientific Validation Published in NEJM Evidence PR Newswire

Published: Dec. 2, 2025, 2 p.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - Business Wire

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia Business Wire

Published: Dec. 2, 2025, 1:05 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!